Cargando…

In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway

The standard treatment for aplastic anemia (AA) in young patients is a matched sibling hematopoietic stem cell transplant. Transfusion of a chronic AA patient with allogeneic bone marrow–derived mesenchymal stromal cells (BMMSCs) is currently being developed as a cell-based therapy, and the safety a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongbo, Wang, Lin, Pang, Yan, Jiang, Zujun, Liu, Zenghui, Xiao, Haowen, Chen, Haijia, Ge, Xiaohu, Lan, Hai, Xiao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307358/
https://www.ncbi.nlm.nih.gov/pubmed/28195151
http://dx.doi.org/10.1038/srep42488
_version_ 1782507357990813696
author Li, Hongbo
Wang, Lin
Pang, Yan
Jiang, Zujun
Liu, Zenghui
Xiao, Haowen
Chen, Haijia
Ge, Xiaohu
Lan, Hai
Xiao, Yang
author_facet Li, Hongbo
Wang, Lin
Pang, Yan
Jiang, Zujun
Liu, Zenghui
Xiao, Haowen
Chen, Haijia
Ge, Xiaohu
Lan, Hai
Xiao, Yang
author_sort Li, Hongbo
collection PubMed
description The standard treatment for aplastic anemia (AA) in young patients is a matched sibling hematopoietic stem cell transplant. Transfusion of a chronic AA patient with allogeneic bone marrow–derived mesenchymal stromal cells (BMMSCs) is currently being developed as a cell-based therapy, and the safety and efficacy of such transfusions are being continuously improved. Nevertheless, the mechanisms by which BMMSCs exert their therapeutic effects remain to be elucidated. In this study, mesenchymal stromal cells (MSCs) obtained from bone marrow donors were concentrated and intravenously injected into 15 chronic AA patients who had been refractory to prior immunosuppressive therapy. We showed that BMMSCs modulate the levels of Th1, Th2, Th17 and Treg cells, as well as their related cytokines in chronic AA patients. Furthermore, the percentages of Th1 and Th17 cells among the H-MSCs decreased significantly, while the percentage Treg cells increased. The Notch/RBP-J/FOXP3/RORγt pathway was involved in modulating the Treg/Th17 balance after MSCs were transfused in vitro. Additionally, the role played by transfused MSCs in regulating the Treg/Th17 balance via the Notch/RBP-J/FOXP3/RORγt pathway was further confirmed in an AA mouse model. In summary, in humans with chronic AA, BMMSCs regulate the Treg/Th17 balance by affecting the Notch/RBP-J/FOXP3/RORγt pathway.
format Online
Article
Text
id pubmed-5307358
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53073582017-02-22 In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway Li, Hongbo Wang, Lin Pang, Yan Jiang, Zujun Liu, Zenghui Xiao, Haowen Chen, Haijia Ge, Xiaohu Lan, Hai Xiao, Yang Sci Rep Article The standard treatment for aplastic anemia (AA) in young patients is a matched sibling hematopoietic stem cell transplant. Transfusion of a chronic AA patient with allogeneic bone marrow–derived mesenchymal stromal cells (BMMSCs) is currently being developed as a cell-based therapy, and the safety and efficacy of such transfusions are being continuously improved. Nevertheless, the mechanisms by which BMMSCs exert their therapeutic effects remain to be elucidated. In this study, mesenchymal stromal cells (MSCs) obtained from bone marrow donors were concentrated and intravenously injected into 15 chronic AA patients who had been refractory to prior immunosuppressive therapy. We showed that BMMSCs modulate the levels of Th1, Th2, Th17 and Treg cells, as well as their related cytokines in chronic AA patients. Furthermore, the percentages of Th1 and Th17 cells among the H-MSCs decreased significantly, while the percentage Treg cells increased. The Notch/RBP-J/FOXP3/RORγt pathway was involved in modulating the Treg/Th17 balance after MSCs were transfused in vitro. Additionally, the role played by transfused MSCs in regulating the Treg/Th17 balance via the Notch/RBP-J/FOXP3/RORγt pathway was further confirmed in an AA mouse model. In summary, in humans with chronic AA, BMMSCs regulate the Treg/Th17 balance by affecting the Notch/RBP-J/FOXP3/RORγt pathway. Nature Publishing Group 2017-02-14 /pmc/articles/PMC5307358/ /pubmed/28195151 http://dx.doi.org/10.1038/srep42488 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Li, Hongbo
Wang, Lin
Pang, Yan
Jiang, Zujun
Liu, Zenghui
Xiao, Haowen
Chen, Haijia
Ge, Xiaohu
Lan, Hai
Xiao, Yang
In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway
title In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway
title_full In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway
title_fullStr In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway
title_full_unstemmed In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway
title_short In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway
title_sort in patients with chronic aplastic anemia, bone marrow–derived mscs regulate the treg/th17 balance by influencing the notch/rbp-j/foxp3/rorγt pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307358/
https://www.ncbi.nlm.nih.gov/pubmed/28195151
http://dx.doi.org/10.1038/srep42488
work_keys_str_mv AT lihongbo inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT wanglin inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT pangyan inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT jiangzujun inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT liuzenghui inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT xiaohaowen inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT chenhaijia inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT gexiaohu inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT lanhai inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway
AT xiaoyang inpatientswithchronicaplasticanemiabonemarrowderivedmscsregulatethetregth17balancebyinfluencingthenotchrbpjfoxp3rorgtpathway